Valuation : Procter & Gamble Health Limited

Market Cap 93.92B 995M 856M 805M 736M 1.38B 1.38B 9.52B 3.69B 48.19B 3.74B 3.65B 155B P/E 2027 *
25.6x
P/E 2028 * 23x
Enterprise Value 93.92B 995M 856M 805M 736M 1.38B 1.38B 9.52B 3.69B 48.19B 3.74B 3.65B 155B EV / Sales 2027 *
6.07x
EV / Sales 2028 * 5.39x
Free-Float
47.81%
Yield 2027 *
1.92%
Yield 2028 * 2.09%
1 day-1.81%
1 week-0.22%
Current month-1.78%
1 month-12.69%
3 months-8.75%
6 months+16.19%
Current year-0.76%
1 week 5,630.05
Extreme 5630.05
5,820
1 month 5,630.05
Extreme 5630.05
6,681.3
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2018
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Director/Board Member 57 01/04/2018
Director/Board Member 51 01/06/2019
Chairman 69 01/04/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%-0.22%-12.42%+13.06% 995M
-0.89%-1.09%+20.02%+71.25% 48.26B
-1.72%-1.15%+47.28%+115.51% 40.5B
-2.01%-5.96%+10.68%+80.50% 11.83B
-0.70%-2.70%-12.22%+11.80% 11.85B
+0.57%-0.56%+26.56%+154.33% 9.36B
-1.67%-0.35%+41.04%-12.04% 7.37B
+0.08%-4.11%+22.91%+43.56% 7.5B
-0.89%-3.09%+22.42%+220.05% 7.28B
-0.16%-2.36%-42.27%+15.39% 5.19B
Average -0.92%-1.93%+12.40%+71.34% 15.01B
Weighted average by Cap. -1.07%-1.71%+23.43%+83.84%

Financials

2027 *2028 *
Net sales 15.47B 164M 141M 133M 121M 227M 227M 1.57B 608M 7.94B 615M 602M 25.58B 17.43B 185M 159M 149M 137M 255M 256M 1.77B 685M 8.94B 693M 678M 28.82B
Net income 3.67B 38.89M 33.46M 31.48M 28.76M 53.8M 53.95M 372M 144M 1.88B 146M 143M 6.07B 4.09B 43.29M 37.25M 35.05M 32.01M 59.89M 60.05M 414M 161M 2.1B 163M 159M 6.76B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
04/09/26 ₹5,657.90 -1.81% 618
03/09/26 ₹5,762.20 +1.46% 353
02/09/26 ₹5,679.10 -1.79% 189
01/09/26 ₹5,782.60 +0.38% 323
31/08/26 ₹5,760.50 +1.59% 1,520
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock